Intellectual Property India Publishes Patent Application for 'Pharmaceutical Injectable Solution Comprising Dopamine' Filed by Inbrain Pharma; Universite De Lille; Centre Hospitalier Universitaire De Lille; and Institut National De La Sante Et De La Recherche Medicale

MUMBAI, India, June 20 -- Intellectual Property India has published a patent application (202517020495 A) filed by Inbrain Pharma; Universite De Lille; Centre Hospitalier Universitaire De Lille; and Institut National De La Sante Et De La Recherche Medicale, Loos, France, on March 6, for 'pharmaceutical injectable solution comprising dopamine.'

Inventor(s) include Odou Pascal; Devos David; Demailly Alexandre; and Fisichella Matthieu.

The application for the patent was published on June 20, under issue no. 25/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a pharmaceutical injectable solution comprising dopamine or a pharmaceutically acceptable salt thereof preferably dopamine...